Corporate News     22-Mar-22
Indoco Remedies receives USFDA approval for Lacosamide Tablets
Used as an anticonvulsant drug
Indoco Remedies received final approval from the United States Food & Drug Administration (USFDA) for Lacosamide Tablets USP 50 mg, 100 mg, 150 mg and 200 mg, the generic version of Vimpat® Tablets of UCB, Inc.

Lacosamide Tablets are indicated for the prevention and control of seizures. It is an anticonvulsant/antiepileptic drug.

Previous News
  Board of Indoco Remedies recommends final dividend
 ( Corporate News - 24-May-23   14:58 )
  Indoco Remedies to purchase land for expansion purpose
 ( Corporate News - 12-Mar-24   17:06 )
  Indoco Remedies receives USFDA approval for Cetirizine Hydrochloride Tablets
 ( Corporate News - 04-Oct-24   14:26 )
  Indoco Remedies to announce Quarterly Result
 ( Corporate News - 15-Jul-22   16:34 )
  Volumes spurt at Mahindra Holidays & Resorts India Ltd counter
 ( Hot Pursuit - 26-May-21   14:30 )
  Indoco Remedies to convene AGM
 ( Corporate News - 03-Jul-21   12:01 )
  Indoco Remedies to table results
 ( Corporate News - 13-Jul-21   12:05 )
  Volumes soar at Indoco Remedies Ltd counter
 ( Hot Pursuit - 05-Mar-21   14:30 )
  Indoco Remedies appoints director
 ( Corporate News - 03-Oct-20   10:41 )
  Indoco Remedies receives ANDA approval for Apixaban Tablets
 ( Corporate News - 14-Sep-20   09:26 )
  Indoco Remedies receives USFDA tentative approval for Canagliflozin Tablets
 ( Corporate News - 06-Dec-23   18:00 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top